NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

生技藥品安全性測試市場調查報告:各實驗類型,各用途-至2025年的預測-COVID-19累積的影響

Biologics Safety Testing Market Research Report by Test Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989813
出版日期 內容資訊 英文 199 Pages
商品交期: 最快1-2個工作天內
價格
生技藥品安全性測試市場調查報告:各實驗類型,各用途-至2025年的預測-COVID-19累積的影響 Biologics Safety Testing Market Research Report by Test Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 199 Pages
簡介

全球生技藥品安全性實驗的市場規模,2020年為38億2,375萬美元/33億5,274萬歐元。該市場,預計至2025年末達68億268萬美元/59億6,472萬歐元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。 本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。

本報告提供生技藥品安全性測試市場的相關調查,市場概要,以及實驗各類型,各用途,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各類型預測
  • 各產品類型預測
  • 各最終用途產業預測
  • 各地區預測
  • 其他各競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響
  • 地理性的成長機會

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球生技藥品安全性測試市場,各實驗類型

  • 簡介
  • 門診病人代理商檢測實驗
  • 微生物附著量實驗
  • 細胞株的認證及特性評估實驗
  • 終局毒素實驗
  • 殘留宿主污染物質檢測實驗
  • 無菌實驗

第7章 全球生技藥品安全性測試市場,各用途

  • 簡介
  • 血液及血液相關產品實驗
  • 細胞及基因治療
  • 幹細胞調查
  • 組織及組織相關產品實驗
  • 疫苗和治療方法的開發

第8章 南北美洲的生技藥品安全性測試市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的生技藥品安全性測試市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲的生技藥品安全性測試市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Avance Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • Cytovance Biologics, Inc.
  • Eurofins Scientific Se
  • Lonza Group Ltd.
  • Merck KGaA
  • Pace Analytical Services Inc.
  • Sartorius AG
  • Source Bioscience
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • Wuxi Apptec

第13章 附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-437D45957966

The Global Biologics Safety Testing Market size was estimated at USD 3,823.75 Million in 2020 and expected to reach USD 4,309.82 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.05% to reach USD 7,982.06 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biologics Safety Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Test Type, the Biologics Safety Testing Market was studied across Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Endotoxin Tests, Residual Host Contaminant Detection Tests, and Sterility Tests.

Based on Application, the Biologics Safety Testing Market was studied across Blood and Blood-Related Products Testing, Cellular and Gene Therapy, Stem Cell Research, Tissue and Tissue-Related Products Testing, and Vaccine & Therapeutics Development.

Based on Geography, the Biologics Safety Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Safety Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Safety Testing Market, including Avance Biosciences Inc., Charles River Laboratories International, Inc., Cytovance Biologics, Inc., Eurofins Scientific Se, Lonza Group Ltd., Merck KGaA, Pace Analytical Services Inc., Sartorius AG, Source Bioscience, Thermo Fisher Scientific Inc., Toxikon Corporation, and Wuxi Apptec.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Biologics Safety Testing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Safety Testing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Safety Testing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Biologics Safety Testing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Biologics Safety Testing Market?
  • 6. What is the market share of the leading vendors in the Global Biologics Safety Testing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Biologics Safety Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Test Type Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the number of drug launches due to high disease burden
      • 5.1.1.2. Rising number of government initiatives
      • 5.1.1.3. Growing size of the biotechnology industry
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising pharmaceutical industries and increasing innovation in the pharmaceutical sector
      • 5.1.3.2. Increasing research and development investment in life sciences and clinical research
    • 5.1.4. Challenges
      • 5.1.4.1. High-cost requirement for development of drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Biologics Safety Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Adventitious Agent Detection Tests
  • 6.3. Bioburden Tests
  • 6.4. Cell Line Authentication and Characterization Tests
  • 6.5. Endotoxin Tests
  • 6.6. Residual Host Contaminant Detection Tests
  • 6.7. Sterility Tests

7. Biologics Safety Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Blood and Blood-Related Products Testing
  • 7.3. Cellular and Gene Therapy
  • 7.4. Stem Cell Research
  • 7.5. Tissue and Tissue-Related Products Testing
  • 7.6. Vaccine & Therapeutics Development

8. Americas Biologics Safety Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Biologics Safety Testing Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Biologics Safety Testing Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Avance Biosciences Inc.
  • 12.2. Charles River Laboratories International, Inc.
  • 12.3. Cytovance Biologics, Inc.
  • 12.4. Eurofins Scientific Se
  • 12.5. Lonza Group Ltd.
  • 12.6. Merck KGaA
  • 12.7. Pace Analytical Services Inc.
  • 12.8. Sartorius AG
  • 12.9. Source Bioscience
  • 12.10. Thermo Fisher Scientific Inc.
  • 12.11. Toxikon Corporation
  • 12.12. Wuxi Apptec

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2026
  • FIGURE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 25. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. CALIFORNIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. FLORIDA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. ILLINOIS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. NEW YORK BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. OHIO BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. PENNSYLVANIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. TEXAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. GLOBAL BIOLOGICS SAFETY TESTING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CALIFORNIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CALIFORNIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. FLORIDA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. FLORIDA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. ILLINOIS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. ILLINOIS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. NEW YORK BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. NEW YORK BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. OHIO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. OHIO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. PENNSYLVANIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. PENNSYLVANIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. TEXAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. TEXAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SCORES
  • TABLE 89. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BUSINESS STRATEGY
  • TABLE 90. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 91. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RANKING
  • TABLE 92. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 93. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SHARE, BY COMPANY, 2020
  • TABLE 94. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MERGER & ACQUISITION
  • TABLE 95. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 96. GLOBAL BIOLOGICS SAFETY TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 97. GLOBAL BIOLOGICS SAFETY TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 98. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 99. GLOBAL BIOLOGICS SAFETY TESTING MARKET: LICENSE & PRICING
  • TABLE 100. GLOBAL BIOLOGICS SAFETY TESTING MARKET: CONTACT DETAILS